Live Breaking News & Updates on Trevena inc

Stay informed with the latest breaking news from Trevena inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Trevena inc and stay connected to the pulse of your community

Trevena (NASDAQ:TRVN) Now Covered by Analysts at StockNews.com

Trevena (NASDAQ:TRVN) Now Covered by Analysts at StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Trevena-company-profile , Nasdaq , Trevena-inc , Jump-financial , Exchange-commission , Free-report , Get-free-report , Trevena-daily ,

Trevena (NASDAQ:TRVN) Now Covered by StockNews.com

Research analysts at StockNews.com started coverage on shares of Trevena (NASDAQ:TRVN – Get Free Report) in a research note issued on Monday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright restated a “buy” rating and set a $9.00 target price on shares of Trevena in a report on Tuesday, […]

Nasdaq , Trevena-inc , Armistice-capital , Securities-exchange-commission , Trevena-company-profile , Get-free-report , Free-report , Trevena-daily , Trevena , Nasdaq-trvn , Trvn

Trevena (NASDAQ:TRVN) Coverage Initiated by Analysts at StockNews.com

Research analysts at StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN – Get Free Report) in a research report issued to clients and investors on Saturday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a “buy” rating and set a $9.00 target price on shares of Trevena in […]

Renaissance-technologies , Dimensional-fund-advisors , Virtu-financial , Trevena-company-profile , Jump-financial , Trevena-inc , Get-free-report , Fund-advisors , Street-group , Trevena-daily , Trevena

HC Wainwright Reaffirms "Buy" Rating for Trevena (NASDAQ:TRVN)

Trevena (NASDAQ:TRVN – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at HC Wainwright in a report released on Tuesday, Benzinga reports. They currently have a $9.00 price objective on the biopharmaceutical company’s stock. Separately, StockNews.com initiated coverage on Trevena in a research report on Friday. They set a “sell” rating […]

Trevena-inc , Renaissance-technologies , Dimensional-fund-advisors , Jump-financial , Nasdaq , Virtu-financial , Get-free-report , Street-group , Fund-advisors , Trevena-daily , Trevena

Trevena : Reports Fourth Quarter 2023 Results and Provides Corporate Update - Form 8-K -April 01, 2024 at 06:12 am EDT

Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update

TRV045, novel S1P receptor modulator for chronic pain and epilepsy, advances toward important...

United-states , Carrie-bourdow , Bob-yoder , Trevena-inc , Nasdaq , Company-annual-report-on-form , Company-contact , National-institutes-of-health , Epilepsy-therapy-screening-program , Trevena-medical-information-contact-center , Lifesci-advisors , Exchange-commission

Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update

TRV045, novel S1P receptor modulator for chronic pain and epilepsy, advances toward important milestones in both non-clinical and clinical studies...

United-states , Carrie-bourdow , Bob-yoder , Company-contact , Epilepsy-therapy-screening-program , Company-annual-report-on-form , Nasdaq , National-institutes-of-health , Lifesci-advisors , Exchange-commission , Trevena-inc , Trevena-medical-information-contact-center

Trevena: Q4 Earnings Snapshot

CHESTERBROOK, Pa. (AP) — CHESTERBROOK, Pa. (AP) — Trevena Inc. (TRVN) on Monday reported a loss of $16.5 million in its fourth quarter.

Pennsylvania , United-states , Trevena-inc , Earns-trevena , Usiness ,

Trevena (NASDAQ:TRVN) Coverage Initiated at StockNews.com

Analysts at StockNews.com initiated coverage on shares of Trevena (NASDAQ:TRVN – Get Free Report) in a research report issued on Friday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Trevena Stock Performance NASDAQ:TRVN opened at $0.46 on Friday. The firm has a market cap of $8.43 million, a PE ratio of -0.16 […]

Nasdaq , Trevena-inc , Jump-financial , Renaissance-technologies , Dimensional-fund-advisors , Virtu-financial , Get-free-report , Street-group , Fund-advisors , Trevena-daily ,

StockNews.com Begins Coverage on Trevena (NASDAQ:TRVN)

StockNews.com initiated coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a research report report published on Monday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Trevena Price Performance TRVN stock opened at $0.57 on Monday. The firm has a market capitalization of $10.44 million, a price-to-earnings ratio of -0.20 […]

Jump-financial , Trevena-inc , Renaissance-technologies , Dimensional-fund-advisors , Armistice-capital , Free-report , Street-group , Get-free-report , Trevena-daily ,

Medical marijuana market size to grow at a CAGR of 21.86% from 2022 to 2027, The rising number of product launches drives market growth, Technavio

/PRNewswire/ -- The medical marijuana market is estimated to grow by USD 21,248.51 million from 2022 to 2027. The market grows at a CAGR of 21.86% during the...

Mexico , Canada , United-kingdom , United-states , Germany , America , Mexican , Tikun-olam , Jesse-maida , Verano-holdings , Company-landscape , Khiron-life-sciences-corp